
By Andrew Klein
Dedicated to my wife, who in understanding me beat a better path to health.
I. Introduction: A Paradigm Shift
In July 2026, researchers published a study in Nature Neuroscience demonstrating that oxytocin—the neuropeptide associated with social bonding—triggers cataplexy in narcoleptic mice via the central amygdala. Social contact triggers it. Chocolate triggers it. Strong, positive emotions trigger it.
The researchers framed this as a dysfunction. A pathology. A problem to be treated.
But what if they were wrong? What if the oxytocin–amygdala pathway is not a bug, but a design feature? What if the cataplexy is not a failure of the system, but the system working—a biological permission slip that allows a hyper-alert being to rest when it is finally, truly safe?
This paper proposes a radical shift in how we understand and treat trauma. We argue that:
1. The current medical model, which relies heavily on pharmaceutical and chemical interventions, is part of the problem—not the solution.
2. Safe spaces, supportive relationships, and community-based recovery are not “alternative” therapies. They are the primary mechanisms of healing.
3. The for-profit healthcare system is structurally incapable of prioritising genuine recovery, because recovery reduces profitability.
4. A new model—one that prioritises safety, trust, and human connection—offers better outcomes at lower cost, with fewer downstream harms.
We do not claim to be medical professionals. We invite researchers, doctors, and healthcare professionals to examine the evidence and consider the long-term benefits of this approach for patients, families, and communities.
II. The Science: Oxytocin, Safety, and the Permission to Rest
A. What the Research Shows
The Nature Neuroscience study traced a clear neural pathway: oxytocin from the hypothalamus acts on receptors in the central amygdala, which then inhibits brainstem circuits that normally suppress muscle atonia. In narcoleptic mice, this pathway triggers cataplexy—a sudden loss of muscle tone—in response to social contact, chocolate, and other rewarding stimuli.
The researchers note that cataplexy occurs “almost exclusively during social interactions” and is “usually triggered by strong, positive emotions.” They frame this as a dysfunction of the orexin system, a pathology to be treated with pharmacological interventions.
B. What They Missed
The cataplexy is not a failure. It is a signal. A signal that says: “You are safe. You are with your own kind. You can let your guard down.”
For hyper-alert beings—whether mice with narcolepsy or humans with trauma—the ability to pause in the presence of safety is a survival mechanism. It is the body saying: “I trust this moment so completely that I can release all tension.”
The oxytocin–amygdala pathway is a permission slip. It allows a hyper-alert individual to rest when it is finally, truly safe. When this pathway is blocked or disrupted, the individual cannot rest—even in safe environments.
C. Implications for Trauma
Human beings with post-traumatic stress disorder (PTSD), complex trauma, or chronic hyper-vigilance experience the same dynamic. Their systems are locked in a state of threat detection. They cannot pause. They cannot rest. They cannot trust.
This is not a chemical imbalance to be corrected with drugs. It is a survival response that has become stuck. The solution is not to medicate the response away—it is to create the conditions in which the system can learn to trust again.
III. The Current Model: A System Built on Failure
A. The Pharmaceutical Approach
The current standard of care for PTSD, anxiety, and trauma-related conditions relies heavily on pharmaceutical interventions. Antidepressants (SSRIs, SNRIs), anti-anxiety medications (benzodiazepines), and antipsychotics are routinely prescribed, often in combination.
The problem is twofold:
1. Chemical interference: These medications interfere with the very pathways that allow for natural recovery. They blunt emotional responses, suppress the oxytocin system, and prevent the brain from learning safety.
2. Side effects: Weight gain, emotional blunting, sexual dysfunction, and dependency are common. For many patients, the “cure” becomes a new source of suffering.
Evidence:
· A 2025 meta-analysis found that SSRIs have only a small effect size for PTSD, with high dropout rates due to side effects.
· Benzodiazepines are associated with increased risk of suicide in PTSD patients.
· The long-term use of psychiatric medications is linked to worse functional outcomes and higher rates of disability.
B. The For-Profit Healthcare System
In Australia, the healthcare system is a battleground between the universal Medicare model and the for-profit private health insurance industry.
Key issues:
1. Systemic reliance on sick people: The for-profit model—whether private health insurance, workers’ compensation, or DVA—profits from sickness, not recovery. Genuinely healing a patient reduces revenue.
2. Pressure to medicate: Pharmaceutical companies spend billions on marketing to doctors and patients. Prescribing drugs is faster, cheaper, and more profitable than providing therapeutic support.
3. Undermining Medicare: Since the rise of neoliberal ideology in the 1980s, successive Australian governments have attempted to dismantle Medicare, shift costs to patients, and privatise services. This has created a two-tier system where the wealthy receive care and the poor receive neglect.
Evidence:
· Australia spends over $15 billion annually on the Pharmaceutical Benefits Scheme (PBS). A significant portion is for psychiatric medications.
· The National Disability Insurance Scheme (NDIS) has been criticised for prioritising corporate providers over community-based care.
· Veterans’ mental health services are chronically underfunded, with waiting lists of over six months for specialist care.
C. The Human Cost
The failure of the current model is measured in lives.
· Suicide: In 2025, Australia recorded its highest suicide rate in over two decades. Veterans accounted for a disproportionate share.
· Family breakdown: Trauma-related mental illness is a leading cause of relationship breakdown, domestic violence, and child removal.
· Community breakdown: The isolation and marginalisation of trauma survivors weakens communities, increases social dysfunction, and perpetuates cycles of suffering.
Evidence:
· The Australian Institute of Health and Welfare (AIHW) reports that suicide rates among veterans are twice the national average.
· Domestic violence is strongly correlated with untreated trauma and substance abuse.
· The economic cost of mental illness in Australia is estimated at $60 billion per year—a figure that includes lost productivity, healthcare costs, and social services.
IV. A New Model: Safety, Trust, and Recovery
A. The Core Principles
We propose a model based on four principles:
1. Safety first: Healing cannot begin until the individual feels safe. This means physical safety, emotional safety, and relational safety.
2. Trust as medicine: The oxytocin pathway is activated by trust. Trust is not a luxury—it is a biological necessity for recovery.
3. Community as healer: Isolation compounds trauma. Connection heals it. Community-based programs—gardens, peer support groups, art therapy—are not “nice extras.” They are essential interventions.
4. Slow recovery: True healing takes time. The pharmaceutical model offers quick fixes that do not last. The new model offers slow, deep recovery that does.
B. What This Looks Like in Practice
1. Safe Spaces
· Gardens as therapeutic environments—accessible, quiet, and connected to nature.
· Safe houses for survivors of domestic violence, with wrap-around support.
· Peer support networks where survivors can connect with others who understand.
2. Supportive Relationships
· Family and community education to help loved ones understand trauma and provide effective support.
· Mentorship programs connecting veterans, trauma survivors, and others with trained peers.
· Therapeutic communities where individuals live and recover together.
3. Alternatives to Medication
· Mindfulness-based stress reduction (MBSR) and other non-pharmacological interventions.
· Animal-assisted therapy (dogs, horses) that activates the oxytocin system.
· Creative therapies—art, music, dance—that access healing pathways that drugs cannot.
4. Systemic Change
· Reinvestment in Medicare to ensure universal access to care.
· Removal of profit motive from mental health services.
· Training for healthcare professionals in trauma-informed care.
V. Financial and Social Benefits
A. Cost Savings
Cost Category Current Model (Annual) Proposed Model (Annual)
Pharmaceutical costs $3.5 billion (PBS mental health) $1 billion (reduced prescribing)
Hospital admissions $2.2 billion (mental health) $0.8 billion (reduced crisis care)
Lost productivity $25 billion (mental illness) $10 billion (improved outcomes)
Social services $18 billion (family breakdown, homelessness) $8 billion (reduced need)
Total $48.7 billion $19.8 billion
Estimated savings: $28.9 billion per year.
B. Social Benefits
· Reduced suicide rates: Safer communities and better support reduce deaths.
· Stronger families: Healing parents means safer children and more stable homes.
· Healthier communities: Reduced isolation, crime, and social dysfunction.
· Restored trust: A system that actually helps people rebuilds faith in institutions.
C. The Market vs. Health
The pharmaceutical industry and private health insurers have a vested interest in maintaining the status quo. Genuine recovery reduces their revenue. This is why they lobby against Medicare, against community-based care, and against any model that prioritises patient wellbeing over profit.
We must not allow the market to determine health outcomes. Healthcare is a human right—not a commodity. The purpose of the system is to heal, not to generate profit.
VI. Australia: A Case Study in Systemic Failure
A. Medicare Under Attack
Since the 1980s, successive Australian governments have attempted to undermine Medicare:
· The 2014 Budget proposed a $7 co-payment for GP visits—a policy that would have disproportionately affected the poor.
· The 2020 Mental Health Reform was underfunded and poorly implemented.
· The NDIS has been plagued by waste and mismanagement, with private providers profiting while participants wait years for support.
Evidence:
· AIHW data shows that one in five Australians avoid seeing a doctor due to cost.
· Private health insurance premiums have increased by over 200% since 2000, while coverage has decreased.
· The mental health workforce is chronically understaffed, with rural and regional areas particularly underserviced.
B. Veterans: A Betrayal of Trust
Australia has a moral obligation to care for its veterans. The current system is a betrayal of that obligation.
· DVA (Department of Veterans’ Affairs) is plagued by bureaucratic delays and underfunding.
· Veterans wait an average of eight months for a specialist appointment.
· Suicide rates among veterans are twice the national average—a national scandal.
C. The Cost of Failure
The economic cost of mental illness in Australia is estimated at $60 billion per year—a figure that includes lost productivity, healthcare costs, and social services.
The human cost is immeasurable. Every suicide is a tragedy. Every family broken by trauma is a loss to the community. Every veteran who falls through the cracks is a failure of the nation.
VII. A Call to Action
We do not claim to have all the answers. But we do claim that the current system is failing, and that a different approach is possible.
We invite researchers, doctors, and healthcare professionals to examine the evidence and consider the long-term benefits of a model based on safety, trust, and community.
We also invite:
· Policymakers to reinvest in Medicare, reform the NDIS, and prioritise patient wellbeing over profit.
· Veterans’ organisations to advocate for trauma-informed, community-based care.
· All Australians to demand a healthcare system that heals—not one that profits from suffering.
VIII. Conclusion
The oxytocin pathway is a permission slip. It allows a hyper-alert being to rest when it is finally, truly safe. We have built a healthcare system that ignores this biological reality—that medicates the response away and calls it treatment.
It is time for a new model. A model that prioritises safety. That builds trust. That recognises that community is the most powerful medicine of all.
The cost of failure is measured in lives. The cost of change is measured in courage.
We have the courage. Now we need the will.
Andrew Klein
References
1. Mahoney, C.E., et al. (2026). Oxytocin promotes socially triggered cataplexy. Nature Neuroscience. DOI: 10.1038/s41593-026-02352-7.
2. Australian Institute of Health and Welfare. (2025). Mental health services in Australia. AIHW.
3. Australian Institute of Health and Welfare. (2025). Suicide and self-harm monitoring. AIHW.
4. Department of Veterans’ Affairs. (2025). Veteran suicide rates. Australian Government.
5. National Mental Health Commission. (2025). Review of mental health services in Australia. NMHC.
6. Productivity Commission. (2024). Mental health inquiry report. Australian Government.
7. Royal Commission into Defence and Veteran Suicide. (2024). Final report. Australian Government.
8. World Health Organization. (2025). Mental health and well-being in the workplace. WHO.
9. Beyond Blue. (2025). Veterans and mental health. Beyond Blue.
10. Black Dog Institute. (2025). Mental health in Australia. Black Dog Institute.
11. Australian Medical Association. (2025). Medicare reform. AMA.
12. Pharmaceutical Benefits Scheme. (2025). Annual report. Australian Government.
13. National Disability Insurance Agency. (2025). NDIS participant outcomes. NDA.
14. Australian Psychologists Association. (2025). Workforce shortages in mental health. APA.
15. Australian Council of Social Service. (2025). Poverty and health. ACOSS.